Arocell Abarocis A Swedish In Vitro Diagnosticsivdcompany Based In Brommastockholmfounded In 2003Arocell Specializes In Developing And Commercializing Tests For Oncological And Bacterial Diseasesthe Company Has Been Publicly Traded On Nasdaq First North Growth Market Sweden Since June 2016 Arocell Focuses On Oncology Diagnosticsparticularly In Monitoring Hematological Malignanciesbreast Cancerand Solid Tumors Using Biomarkers Like Thymidine Kinase 1Tk1 Key Products Include Ubc Rapida Point Of Care Test For Oncological Applicationstk 210 Elisaa Blood Test For Measuring Tk1 Levelsand Tubexatfa Rapid Diagnostic Test For Acute Typhoid Feverthe Company Employs Patented Biomarker Technology And Collaborates With Partners For Development And Salesaiming To Enhance Cancer Patient Management Through Accessible Diagnostic Tools
